Dyne Therapeutics Inc (DYN) Company Profile & Statistics

Dyne Therapeutics Inc
DYN
(Nasdaq - US)
Open
29.00
+0.61 (+2.15%)
in:usd•As of: Nov 18, 2024 12:35 UTC -5
Open
28.20
High
29.08
Low
27.18

About Dyne Therapeutics Inc

CEO

Joshua Brumm

Headquarters

1560 trapelo road

waltham, ma 02451, united states

Auditor

Deloitte & Touche LLP

Employees

141

Share Holders

Website

www.dyne tx.com

Industry

biotechnology

Sector

health technology

Company Overview

Dyne Therapeutics Inc. is a muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. The company's proprietary platform includes FORCE(TM). Dyne Therapeutics Inc. is based in WALTHAM, Mass.

Dyne Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	2.95B
Enterprise Value	2.42B
Enterprise Value/EBITDA (ttm)	-7.66
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	4.09
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	0.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	0.00%
Return on Equity (ttm)	-57.46%
Return on Invested Capital (ttm)	-108.89%
Return on Assets (ttm)	-51.62%

Income Statement

Revenue (ttm)	0.00
Revenue Per Share (ttm)	0.00
Gross Profit (ttm)	0.00
EBITDA (ttm)³	-315.81M
Net Income Avi to Common (ttm)	-294.51M
Diluted EPS (ttm)	-3.56

Share Statistics

Beta (5Y Monthly)	1.10
52-Week Change	172.30%
S&P500 52-Week Change	29.62%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	101.77M
Dividend Yield	0.00%
Float ⁴	80.63M
% Held by Insiders	20.77%
% Held by Institutions	96.68%

Balance Sheet

Total Cash (mrq)	723.67M
Total Cash Per Share (mrq)	7.11
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	17.02%
Quick Ratio (mrq)	17.02%
Book Value Per Share (mrq)	6.93

Cash Flow

Operating Cash Flow Per Share (ytd)	-2.06
Free Cash Flow (ytd)	-209.34M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Dyne Therapeutics Inc

Trade With A Regulated Broker